• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    NextGen Healthcare Announces Retirement of Chief Medical Officer Betty Rabinowitz and Promotion of Robert Murry to Chief Medical Officer

    12/15/21 8:00:00 AM ET
    $NXGN
    EDP Services
    Technology
    Get the next $NXGN alert in real time by email

    NextGen Healthcare, Inc. (NASDAQ:NXGN), a leading provider of ambulatory-focused technology solutions, today announced the retirement of its chief medical officer, Betty Rabinowitz, MD, FACP, effective December 31, 2021. Dr. Rabinowitz joined the company in 2017, following her role as one of the founders and former CEO of EagleDream Health, the cloud-based analytics and population management solution acquired by NextGen Healthcare. "Dr. Betty" as she is known in the industry, was appointed to the newly created chief medical officer role in 2018. Her lengthy healthcare career spans over 40 years and includes extensive clinical and academic experience.

    This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20211215005385/en/

    Dr. Robert Murry, Chief Medical Officer for NextGen Healthcare (Photo: Business Wire)

    Dr. Robert Murry, Chief Medical Officer for NextGen Healthcare (Photo: Business Wire)

    The company also announced that, following an external and internal search, its chief medical Informatics officer (CMIO), Robert (Bob) Murry, Ph.D., M.D., FAAFP, has been promoted to chief medical officer. Dr. Murry has been with NextGen Healthcare since 2012 and has guided the company's strategy and vision for select products and services. Under his leadership, the company's NextGen® Enterprise solution has risen to become the top-rated ‘Best in KLAS' ambulatory electronic health record system (11-75 physicians) in 2021. Previously, Dr. Murry served as Medical Director for Ambulatory Informatics and CMIO for Hunterdon Medical Center while practicing family medicine at Delaware Valley Health Center.

    "On behalf of the entire NextGen Healthcare team, I would like to thank Dr. Betty for her invaluable contributions to our company and the healthcare industry throughout her career, particularly as a pioneer of population health solutions for ambulatory providers," said David Sides, president and chief executive officer for NextGen Healthcare. "She has played a pivotal role in NextGen Healthcare's growth. We are grateful for her friendship, vision and commitment to better healthcare for all. We wish her the very best in retirement."

    Sides continued, "I would also like to congratulate Dr. Bob on his promotion to chief medical officer – a role which he is extremely well suited for given his wealth of clinical experience, technical knowledge and long-term, trusted relationship with our clients. I am confident he will flourish as CMO and he will build on the outstanding foundation established by Dr. Betty."

    About NextGen Healthcare, Inc.

    NextGen Healthcare, Inc. (NASDAQ:NXGN) is a leading provider of ambulatory-focused technology solutions. We are empowering the transformation of ambulatory care—partnering with medical, behavioral and dental providers in their journey to value-based care to make healthcare better for everyone. We go beyond EHR and PM. Our integrated solutions help increase clinical productivity, enrich the patient experience, and ensure healthy financial outcomes. We believe in better. Learn more at nextgen.com, and follow us on Facebook, Twitter, LinkedIn, YouTube and Instagram.

    View source version on businesswire.com: https://www.businesswire.com/news/home/20211215005385/en/

    Get the next $NXGN alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $NXGN

    DatePrice TargetRatingAnalyst
    8/28/2023$21.00Overweight
    Cantor Fitzgerald
    4/12/2023$24.00Overweight
    Stephens
    10/21/2022$20.00Neutral
    Piper Sandler
    9/7/2022$20.00Hold
    Truist
    5/6/2022$26.00Neutral → Buy
    Guggenheim
    4/14/2022Neutral
    Guggenheim
    1/6/2022$22.00Mkt Perform → Outperform
    SVB Leerink
    1/6/2022Market Perform → Outperform
    SVB Leerink
    More analyst ratings

    $NXGN
    SEC Filings

    See more
    • SEC Form 15-12G filed by NextGen Healthcare Inc.

      15-12G - NEXTGEN HEALTHCARE, INC. (0000708818) (Filer)

      11/20/23 4:38:55 PM ET
      $NXGN
      EDP Services
      Technology
    • SEC Form S-8 POS filed by NextGen Healthcare Inc.

      S-8 POS - NEXTGEN HEALTHCARE, INC. (0000708818) (Filer)

      11/9/23 9:22:56 AM ET
      $NXGN
      EDP Services
      Technology
    • SEC Form S-8 POS filed by NextGen Healthcare Inc.

      S-8 POS - NEXTGEN HEALTHCARE, INC. (0000708818) (Filer)

      11/9/23 9:20:26 AM ET
      $NXGN
      EDP Services
      Technology